W. Hevers, H. Luddens (1998). The diversity of GABAAreceptors: pharmacological and
electrophysiological properties of GABAAchannel subtypes. Mol. Neurobiol. 18: 35.
J. K. Ho, R. A. Harris (1981). Mechanism of action of barbiturates. Annu. Rev. Pharmacol.
Toxicol. 21 : 83–111.
R. Hoehn-Saric (1998). Generalized anxiety disorder: Guidelines to diagnosis and treatment.
CNS Drugs 9: 85.
G. A. R. Johnson, M. Willow (1982). GABA and barbiturate receptors. In: J. W. Lamble (Ed.).
More About Receptors. Amsterdam: Elsevier Biochemical Press.
G. A. R. Johnson, M. Chebib, J. R. Hanrahan, K. N. Mewett (2003). GABAC receptors as drug
targets. Curr. Drug Targets:CNS Neurol. Dis. 2: 260–268.
E. R. Korpi, G. Grunder, H. Luddens (2002). Drug interactions at GABAA receptors. Prog.
Neurobiol. 67 : 113–159.
M. D. Krasowski, N. L. Harrison (1999). General anaesthetic action on ligand-gated ion chan-
nels.Cell. Mol. Life Sci. 55: 1278.
P. Krogsgaard-Larsen, P. Jacobsen, E. Falch, H. Hjeds (1982). GABA-agonists: chemical, mole-
cular, pharmacologic and therapeutic aspects. In: A. M. Creighton, S. Turner (Eds.). The
Chemical Regulation of Biological Mechanisms. London: Royal Society of Chemistry.
M. Lancel (1999). Role of GABAAreceptors in the regulation of sleep: Initial sleep responses
to peripherally administered modulators and agonists. Sleep 22: 33.
H. Luddens, E. R. Korpi (1995). Biological function of GABA-A/benzodiazepine receptor
heterogeneity. J. Psychiatr. Res. 29: 77.
A. Manocha (1998). Pharmacology of GABAc receptors. Ind. J. Pharmacol. 30 : 218–226.
S. P. Nordt, R. F. Clark (1997). Midazolam: a review of therapeutic uses and toxicity. J. Emerg.
Med. 15: 357.
E. J. Peck, Jr (1980). Receptors for amino acids. Annu. Rev. Physiol. 42: 615–627.
G. Racagni, A. O. Donoso (Eds.) (1986). GABA and Endocrine Functions. New York: Raven Press.
J. G. Richards, P. Schoch, H. Möhler, W. Haefely (1986). Benzodiazepine receptors resolved.
Experientia 42: 121–126.
R. Sankar, D. F. Weaver (1997). Antiepileptic drugs: basic principles of medicinal chemistry. In:
J. Engel, T. Pedley (Eds.). Epilepsy:A Comprehensive Textbook. Philadelphia: Lippincott-
Raven, vol 2, pp. 1393–1403.
P. Skolnick, S. M. Paul (1981). Benzodiazepine receptors. Annu. Rep.Med. Chem. 16: 21–29.
M. Steriade (2004). Local gating of information processing through the thalamus. Neuron 41:
493–494.
G. Toffamo, A. Leon, M. Massotti, A. Guidotti, E. Costa (1980). GABA-modulin: a regulating
protein for GABA receptors. In: G. Pepeu, M. J. Kuhar, S. J. Enna (Eds.). Receptors for
Neurotransmitters and Peptide Hormones. New York: Raven Press, pp. 132–142.
S. Vicini (1999). New perspectives in the functional role of GABAAchannel heterogeneity. Mol.
Neurobiol. 19: 97.
A. Wassef, J. Baker, L. D. Kochan (2003). GABA and schizophrenia: a review of basic science
and clinical studies. J. Clin. Psychopharmacol. 23 : 601–640.
P. J. Whiting (1999). The GABAAreceptor gene family: new targets for therapeutic intervention.
Neurochem. Int. 34: 387.
P. J. Whiting (2003). GABA-A receptor subtypes in the brain: a paradigm for CNS drug discovery?
Drug Discov. Today 8: 445–450.
M. Williams, N. Yokoyama (1986). Anxiolytics, anticonvulsants and sedative hypnotics. Annu.
Rep. Med. Chem. 21: 11–20.
C. F. Zorumsky, K. E. Isenberg (1991). Insights into the structure and function of GABA-
benzodiazepine receptors: ion channels and psychiatry. Am. J. Psychiatry 148: 162.
NEUROTRANSMITTERS AND THEIR RECEPTORS 307